cTnT、cys C和NT-proBNP联合检测在心力衰竭患者诊断中的应用价值

doi:10.3969/j.issn.1671-7171.2024.08.006

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (1161 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To explore the clinical value of combined detection of serum cardiac troponin T (cTnT), cystatin C (cys C), and N-terminal pro-B-type natriuretic peptide (NT-proBNP) in the diagnostic process of heart failure patients.【Methods】 Fifty heart failure patients treated in our hospital were selected as the observation group, and 40 healthy individuals undergoing physical examination during the same period were selected as the control group. The levels of cTnT, cys C, and NT-proBNP were compared between the two groups. The levels of cTnT, cys C, and NT-proBNP were also compared among patients with different grades of cardiac function in the observation group, as well as the changes in these indicators before and after treatment in the patients.【Results】 The levels of cTnT, cys C, and NT-proBNP at admission in the observation group were significantly higher than those in the control group, with statistically significant differences (P<0.05). Among the 50 heart failure patients, the levels of cTnT, cys C, and NT-proBNP decreased from cardiac function grade Ⅳ to grade Ⅱ, with statistically significant differences between patients of different grades (P<0.05). The levels of cTnT, cys C, and NT-proBNP at discharge after treatment in the observation group were significantly lower than those before treatment (P<0.05).【Conclusion】 Combined detection of cTnT, cys C, and NT-proBNP has diagnostic value in the process of diagnosing heart failure patients and is also important for evaluating the prognosis of heart failure treatment.

Key words： Heart Failure/DI Troponin T/BL Chalones/BL Natriuretic Peptide, Brain/BL

Received: 10 January 2024

PACS:

R541.61

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	SUN Xiaolan
	CHEN Min
	JIANG Danma

Cite this article:

SUN Xiaolan,CHEN Min,JIANG Danma. Application Value of Combined Detection of cTnT, cys C, and NT-proBNP in Diagnosing Heart Failure Patients[J]. JOURNAL OF CLINICAL RESEARCH, 2024, 41(8): 1138-1140.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2024.08.006 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2024/V41/I8/1138

[1] 陈忠锐. NT-proBNP、HGF和GDF-15在射血分数保留型心力衰竭患者中的表达及预后价值[J].中国医学创新,2021,18(30):15-20.
[2] 朱晓峰,伍惠静. 胱抑素C心肌肌钙蛋白I和N末端-脑钠肽前体联合检测对老年心力衰竭的诊断价值[J].山西医药杂志,2019,48(15):1907-1909.
[3] 吕海珍,吕云,周荣,等. 血清Hcy、sST2和NT-proBNP联合检测对慢性心力衰竭诊断及心功能评价的价值[J].中国实验诊断学,2019,23(6):1002-1006.
[4] 王佩青.半乳糖凝集素3在慢性心力衰竭患者血浆中的表达及其临床意义[D]. 河南:郑州大学,2022.
[5] 黎百志. 外周血线粒体DNA、生长分化因子-15联合脑钠肽检测对心力衰竭的诊断价值[D].河北:承德医学院,2021.
[6] 仲璟. HFA-PEFF评分E步对射血分数保留的心力衰竭患者诊断和筛查的价值[D]. 江苏:苏州大学,2021.
[7] 党彩静,张婧,何珊,等. 老年重症射血分数保留心力衰竭患者临床特点及预后分析[J].中国实用内科杂志,2021,41(8):710-714.
[8] 金自慧,杨大英.血清可溶性生长刺激表达基因2蛋白和高迁移率族蛋白B1对老年急性心力衰竭患者预后的评估价值[J].中国医药 2021,16(3): 326-330.
[9] 吕海珍,吕云,周荣,等.血清Hcy、sST2和NT-proBNP联合检测对慢性心力衰竭诊断及心功能评价的价值[J].中国实验诊断学, 2019, 23(6):1002-1006.
[10] 李妙男. 血浆N-乙酰-神经氨酸水平和急性冠脉综合征患者临床诊断、危险分层及临床预后之间的相关性研究[D]. 山东:山东大学,2021.
[11] 张胜睿,张敏,杨栋梁,等.急性和慢性心力衰竭患者生化指标的检测及其临床意义[J].实用临床医学, 2019, 20(9):1-3.
[12] 马振薇.浅谈生化指标联合检测在心力衰竭诊断中的应用价值观察[J].中文科技期刊数据库(全文版)医药卫生, 2022(12):3.